NVST logo

Envista Holdings Corporation (NVST)

$24.50

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on NVST

Market cap

$3.99B

EPS

0.41

P/E ratio

63.2

Price to sales

1.51

Dividend yield

--

Beta

0.884563

Price on NVST

Previous close

$24.06

Today's open

$24.16

Day's range

$23.81 - $24.52

52 week range

$18.25 - $30.42

Profile about NVST

CEO

Paul Keel

Employees

12000

Headquarters

Brea, CA

Exchange

New York Stock Exchange

Shares outstanding

162727923

Issue type

Common Stock

NVST industries and sectors

Healthcare

Medical Equipment & Supplies

News on NVST

Here's Why You Should Retain NVST Stock in Your Portfolio for Now

Envista Holdings Corporation's NVST ongoing international expansion is strengthening its presence across a broader range of markets, creating significant opportunities for long-term growth. Supported by the company's strategic priorities and growth-focused initiatives, it is well positioned to capitalize on emerging opportunities and deliver solid operational and financial performance in the upcoming quarters.

news source

Zacks Investment Research • Jun 8, 2026

news preview

Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?

Envista (NVST) reported earnings 30 days ago. What's next for the stock?

news source

Zacks Investment Research • Jun 5, 2026

news preview

Is NVST Attractive at 15.1x Forward Earnings?

Envista trades at 15.1x forward earnings; Q1 2026 profit surged, and a $24 target hinges on sustaining margins and sales gains.

news source

Zacks Investment Research • Jun 4, 2026

news preview

NVST Stock Explained for 2026 Growth Drivers and Risks

Envista targets margin gains via its Business System while boosting R&D and buybacks, with a $24 6-12 month target vs $22.94.

news source

Zacks Investment Research • Jun 3, 2026

news preview

Here's Why Envista (NVST) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Jun 2, 2026

news preview

Why Envista (NVST) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • May 15, 2026

news preview

Envista Q1 Earnings Call Highlights

Envista NYSE: NVST reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commercial capabilities.

news source

MarketBeat • May 13, 2026

news preview

Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win

With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investors are hunting for defensive names that can grow even as households tighten budgets.

news source

24/7 Wall Street • May 13, 2026

news preview

Envista (NVST) International Revenue Performance Explored

Explore Envista's (NVST) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

news source

Zacks Investment Research • May 11, 2026

news preview

Why Envista (NVST) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • May 8, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Envista Holdings Corporation

Open an M1 investment account to buy and sell Envista Holdings Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in NVST on M1